Clinical decision support
Decision support that turns guidelines and data into individualized, safe, explainable recommendations clinicians can trust.
Healthcare AI, done responsibly.
Dr. Damon Tojjar builds and validates clinical AI for diabetes and chronic disease. The standard is simple: clinically grounded, validated in real settings, and useful inside a clinician's workflow, not hype.
Capabilities
Decision support that turns guidelines and data into individualized, safe, explainable recommendations clinicians can trust.
Designing the evidence (including randomized trials) that shows a tool actually improves care, not just benchmarks.
EU MDR, IVDR, FDA pathways, and Software as a Medical Device, informed by a KTH certificate and FDA training.
Moving a tool from concept to the clinic, drawing on global development experience at Novo Nordisk.
Worked example
An AI-based clinical decision-support system for type 2 diabetes, developed with patients, clinicians, and researchers. Its randomized controlled trial, EASY-1 (NCT03258268), compared the system against standard of care. EASY Diabetes received the Medtech4Health Innovation Award.
Frequently asked
Software that helps clinicians make better decisions by turning patient data and evidence into individualized, safe recommendations. Dr. Tojjar's EASY Diabetes is an example, evaluated in the EASY-1 randomized controlled trial.
Clinically grounded, validated in real clinical settings, designed to fit the workflow, and accountable. He pairs medical training with global clinical development experience and medical device regulation expertise.
A physician-scientist (M.D., Ph.D. candidate) and digital health entrepreneur working on diabetes research, clinical medicine, and AI-driven care.
Contact
For advisory work, collaboration on clinical AI, or speaking, reach out directly.